Docoh
Loading...

ANIK Anika Therapeutics

Anika Therapeutics, Inc. is an orthopedic and regenerative medicines company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company was founded in 1992 and is headquartered in Bedford, MA.

Company profile

Ticker
ANIK
Exchange
CEO
Joseph Darling
Employees
Incorporated
Location
Fiscal year end
Former names
ANIKA RESEARCH INC, ANIKA THERAPEUTICS INC
SEC CIK
IRS number
43145961

ANIK stock data

(
)

Calendar

5 Mar 21
13 Apr 21
31 Dec 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 95.82M 95.82M 95.82M 95.82M 95.82M 95.82M
Cash burn (monthly) 2.8M 5.14M 6.05M 2.39M (positive/no burn) (positive/no burn)
Cash used (since last report) 9.67M 17.75M 20.89M 8.24M n/a n/a
Cash remaining 86.14M 78.07M 74.93M 87.58M n/a n/a
Runway (months of cash) 30.8 15.2 12.4 36.7 n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
9 Mar 21 David Colleran Stock Option Common Stock Grant Aquire A No No 37.4 27,681 1.04M 27,681
9 Mar 21 David Colleran RSU Common Stock Grant Aquire A No No 0 11,047 0 11,047
9 Mar 21 Blanchard Cheryl R Stock Option Common Stock Grant Aquire A No No 37.4 108,398 4.05M 108,398
9 Mar 21 Blanchard Cheryl R RSU Common Stock Grant Aquire A No No 0 43,259 0 43,259
9 Mar 21 Thomas Finnerty Stock Option Common Stock Grant Aquire A No No 37.4 19,158 716.51K 19,158
9 Mar 21 Thomas Finnerty RSU Common Stock Grant Aquire A No No 0 7,645 0 7,645
9 Mar 21 Michael L Levitz Stock Option Common Stock Grant Aquire A No No 37.4 33,363 1.25M 33,363
9 Mar 21 Michael L Levitz RSU Common Stock Grant Aquire A No No 0 13,315 0 13,315
9 Mar 21 Loerop James Stock Option Common Stock Grant Aquire A No No 37.4 16,802 628.39K 16,802
9 Mar 21 Loerop James RSU Common Stock Grant Aquire A No No 0 6,705 0 6,705

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

94.5% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 166 161 +3.1%
Opened positions 22 19 +15.8%
Closed positions 17 20 -15.0%
Increased positions 41 51 -19.6%
Reduced positions 69 49 +40.8%
13F shares
Current Prev Q Change
Total value 612.67M 481.1M +27.3%
Total shares 13.54M 13.59M -0.4%
Total puts 16K 13.7K +16.8%
Total calls 685.5K 958.3K -28.5%
Total put/call ratio 0.0 0.0 +63.3%
Largest owners
Shares Value Change
BLK Blackrock 2.25M $101.85M +5.1%
Kayne Anderson Rudnick Investment Management 1.55M $69.98M +3.7%
AMP Ameriprise Financial 1M $45.45M -0.3%
Vanguard 934.28K $42.29M +2.6%
Dimensional Fund Advisors 884.12K $40.02M -4.1%
STT State Street 820.75K $37.15M +5.5%
Renaissance Technologies 809.12K $36.62M -3.3%
Avidity Partners Management 731K $33.09M +21.5%
Boston Trust Walden 378.17K $17.12M +0.7%
NTRS Northern Trust 229.76K $10.4M -4.0%
Largest transactions
Shares Bought/sold Change
Avidity Partners Management 731K +129.3K +21.5%
BLK Blackrock 2.25M +108.87K +5.1%
Baird Financial 136.3K -103.07K -43.1%
Parian Global Management 102.71K +81.41K +382.2%
FHI Federated Hermes 9.18K -71.34K -88.6%
Acadian Asset Management 7.8K -70.63K -90.1%
Russell Investments 206.46K +66.24K +47.2%
Kayne Anderson Rudnick Investment Management 1.55M +54.65K +3.7%
Aqr Capital Management 0 -53.8K EXIT
Archon Capital Management 48.93K +48.93K NEW

Financial report summary

?
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: absent, abundance, accessibility, accuracy, aforementioned, agile, altogether, analyst, anatomy, array, arrive, Arthroplasty, arthroscopic, aspect, assumed, attendance, avoid, avoided, back, Bureau, Button, Carlo, carryforward, caution, chain, cleaning, coaching, College, combating, Commerce, commonly, conclusion, conference, consigned, consignment, contributory, cyber, cybersecurity, deep, diligently, dissemination, diverted, DOJ, dose, downstream, dramatically, drawdown, drew, duration, easing, email, encourage, Energized, entrepreneurial, epidemic, evolutionary, exacerbate, factor, faster, feasible, FIFO, flexibility, fluctuating, forma, fulltime, fundamental, grew, hall, home, homogenized, HyaloBone, hypothetical, ill, impossible, imprisonment, inadvertent, inadvisable, indirectly, Indonesia, infection, intervention, investor, Johnson, judgement, judgment, lapse, Levitz, lifestyle, light, live, living, macroeconomic, manipulation, mathematical, MDD, mentoring, Mexico, Michael, mimic, Monte, MPEEM, NaN, OA, obsolescence, occasional, OFAC, onsite, opportunistic, outsourced, pace, pandemic, peer, people, phishing, physical, PLC, policymaking, possession, precaution, precipitously, presence, principle, prioritize, prioritized, pro, proceed, progression, prohibited, proper, punishable, purport, qualitative, ramp, rationalization, recapture, recommended, recreate, refinement, regular, reliance, remote, remotely, repaid, resurfacing, rollforward, safe, scenario, scrutiny, seasonal, sick, simulated, simulation, situation, sizeable, social, span, sparing, specialist, stability, Stark, Statute, stay, strive, sum, suture, Teamwork, thing, tool, town, traditional, travel, Treasurer, TSR, tuition, turnover, uncollectible, Unitholder, unpredictability, unutilized, Vice, vital, vulnerable, Western, widespread, WIP, Wisconsin, withdrew, workforce, workplace, worn, WristMotion
Removed: aesthetic, aid, ANIKAVISC, animal, ascertain, attempt, automatically, boycotted, broader, Bulletin, Canada, candidate, center, chemically, commercialized, compatible, composed, computer, conservative, consulting, contamination, continuum, debilitating, debridement, dermal, dermatology, diabetic, dispute, disruptive, dissolved, East, eliminate, employment, ENT, fifteen, filler, finalized, fleece, gel, good, hacking, half, healing, HYALOFILL, HYDRELLE, illegal, inactivate, investee, IRS, judged, jurisdiction, landlord, Latin, leadership, licensing, locate, Medtronic, MEROGEL, Middle, moderate, modestly, nasal, negligence, notify, Notwithstanding, owner, partner, partnered, patented, permitting, predicting, procure, project, projecting, protected, protested, provisional, ratio, reach, reaching, regenerating, relationship, relocation, renegotiation, rent, resource, run, skin, smoothly, suitable, swelling, synovial, terrorism, threshold, transmission, utilization, vandalism, variability, wage, warehousing, withdraw, woven, XoMed